↓ Skip to main content

A randomized, placebo-controlled clinical trial evaluating the safety and efficacy of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus inadequately controlled by…

Overview of attention for article published in BMC Endocrine Disorders, November 2017
Altmetric Badge

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
89 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A randomized, placebo-controlled clinical trial evaluating the safety and efficacy of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus inadequately controlled by glimepiride and metformin
Published in
BMC Endocrine Disorders, November 2017
DOI 10.1186/s12902-017-0219-x
Pubmed ID
Authors

Seung-Hwan Lee, Ira Gantz, Elizabeth Round, Melanie Latham, Edward A. O’Neill, Paulette Ceesay, Shailaja Suryawanshi, Keith D. Kaufman, Samuel S. Engel, Eseng Lai

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 89 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 16 18%
Student > Master 11 12%
Student > Doctoral Student 6 7%
Student > Postgraduate 5 6%
Researcher 5 6%
Other 11 12%
Unknown 35 39%
Readers by discipline Count As %
Medicine and Dentistry 27 30%
Nursing and Health Professions 11 12%
Pharmacology, Toxicology and Pharmaceutical Science 5 6%
Biochemistry, Genetics and Molecular Biology 4 4%
Agricultural and Biological Sciences 2 2%
Other 3 3%
Unknown 37 42%